Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
Odyssey Health (OTCQB: ODYY) has announced plans to advance the development of its patented Save A Life (SAL) choking rescue device, targeting an FDA submission in 2026. The device is designed as a vacuum-based solution for removing lodged objects from a choking victim's throat.
The SAL device features a vacuum chamber with a replaceable mouthpiece that can be quickly deployed in emergencies. When activated, it creates an appropriate vacuum force to dislodge throat obstructions without causing trauma to the victim. The company highlights the significant market need, citing 5,000 annual choking deaths in the US and over 100,000 yearly emergency room visits related to choking incidents.
Odyssey Health (OTCQB: ODYY) ha annunciato l'intenzione di proseguire lo sviluppo del suo dispositivo brevettato per il salvataggio in caso di soffocamento, il Save A Life (SAL), con l'obiettivo di presentare domanda alla FDA nel 2026. Il dispositivo è stato progettato come soluzione basata sul vuoto per rimuovere oggetti bloccati nella gola della persona che sta soffocando.
Il SAL è dotato di una camera a vuoto con un boccaglio sostituibile, rapidamente utilizzabile nelle situazioni di emergenza. Una volta attivato, genera la forza di aspirazione necessaria per dislocare le ostruzioni della gola senza provocare traumi alla vittima. L'azienda sottolinea l'ampia necessità di mercato, citando 5.000 decessi annuali per soffocamento negli Stati Uniti e oltre 100.000 accessi annui in pronto soccorso legati a episodi di soffocamento.
Odyssey Health (OTCQB: ODYY) ha anunciado planes para avanzar en el desarrollo de su dispositivo patentado de rescate contra la asfixia, Save A Life (SAL), con la meta de presentar una solicitud ante la FDA en 2026. El dispositivo está diseñado como una solución basada en vacío para extraer objetos alojados en la garganta de una persona que se está atragantando.
El SAL cuenta con una cámara de vacío y una boquilla reemplazable que puede desplegarse rápidamente en emergencias. Al activarse, crea la fuerza de succión adecuada para desalojar las obstrucciones en la garganta sin causar traumatismos a la víctima. La compañía destaca la importante necesidad en el mercado, citando 5.000 muertes anuales por asfixia en EE. UU. y más de 100.000 visitas anuales a urgencias relacionadas con episodios de atragantamiento.
Odyssey Health (OTCQB: ODYY)는 자사의 특허받은 실명 구조 장치인 Save A Life (SAL)의 개발을 진행하여 2026년 FDA 제출을 목표로 하고 있다고 발표했습니다. 이 장치는 질식한 환자의 목에 걸린 물체를 제거하기 위한 진공 기반 솔루션으로 설계되었습니다.
SAL 장치는 교체 가능한 마우스피스를 갖춘 진공 챔버를 특징으로 하며, 긴급 상황에서 신속히 사용할 수 있습니다. 작동 시 적절한 흡입력을 발생시켜 목의 이물질을 외상 없이 제거하도록 설계되었습니다. 회사는 연간 미국 내 5,000건의 질식사와 질식 관련 연간 100,000건 이상의 응급실 방문을 언급하며 시장의 큰 필요성을 강조했습니다.
Odyssey Health (OTCQB: ODYY) a annoncé son intention de poursuivre le développement de son dispositif breveté de sauvetage contre l'étouffement, le Save A Life (SAL), visant un dossier auprès de la FDA en 2026. L'appareil est conçu comme une solution par aspiration pour retirer des objets coincés dans la gorge d'une personne en train de s'étouffer.
Le SAL comporte une chambre à vide avec un embout remplaçable, rapidement déployable en cas d'urgence. Une fois activé, il crée la force d'aspiration adéquate pour déloger les obstructions sans provoquer de traumatisme chez la victime. La société souligne le besoin important sur le marché, citant 5 000 décès annuels par étouffement aux États-Unis et plus de 100 000 visites annuelles aux urgences liées à des épisodes d'étouffement.
Odyssey Health (OTCQB: ODYY) hat Pläne bekannt gegeben, die Entwicklung seines patentierten Erstickungsrettungsgeräts Save A Life (SAL) voranzutreiben und strebt eine FDA-Einreichung im Jahr 2026 an. Das Gerät ist als vakuumbasierte Lösung konzipiert, um in der Kehle festsitzende Gegenstände bei Erstickungsopfern zu entfernen.
Das SAL verfügt über eine Vakuumkammer mit austauschbarem Mundstück, die im Notfall schnell einsatzbereit ist. Nach Aktivierung erzeugt es die erforderliche Saugkraft, um Halsverlegungen zu lösen, ohne der betroffenen Person Verletzungen zuzufügen. Das Unternehmen verweist auf den erheblichen Marktbedarf und nennt 5.000 jährliche Todesfälle durch Ersticken in den USA sowie über 100.000 jährliche Notaufnahmebesuche im Zusammenhang mit Erstickungsfällen.
- Development of innovative life-saving medical device addressing a significant market need
- Patent protection secured for the Save A Life choking rescue device
- Large potential market with 5,000 annual choking deaths and 100,000 ER visits in the US
- Device designed for rapid response and ease of use in emergency situations
- FDA submission not planned until 2026, indicating a lengthy development timeline
- Currently only at prototype stage, significant development work still needed
- Will require regulatory approval before commercialization
Company to Advance Development of its Patented Device
LAS VEGAS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY) (the “Company” or “Odyssey”), a technology and asset acquisition company focused on developing unique, life-saving medical products is pleased to provide the following update on the development of its Save A Life (“SAL”) choking rescue device. Odyssey has created a prototype device and now plans to continue the advancement of the product with the ultimate goal of filing a submission to the FDA for the life-saving choking rescue device.
The Save a Life anti-choking device is a patented, safe, and easy to use vacuum device for removing a lodged mass or bolus from the throat of a choking victim. The device includes a pump for creating a vacuum chamber which is connected seamlessly with a replaceable/disposable mouthpiece. In an emergency SAL may be easily inserted into the victim’s mouth which depresses the tongue providing a clear, trauma-free application. By pressing a button on the device, the device will deliver the appropriate amount of instantaneous vacuum to dislodge the mass or bolus in the throat without harm or damage to the victim. The application is instantly effective as the device is operational and effective in a matter of seconds.
“We plan to advance the development of our Save A Life choking rescue device with our eyes on an FDA submission in 2026,” commented Odyssey President and Chief Executive Officer Michael Redmond. With approximately 5,000 choking deaths annually in the US in
About Odyssey Health, Inc.
Odyssey Health, Inc. (OTCQB: ODYY) is a technology company with a focus in the area of life saving medical solutions. Odyssey’s corporate mission is to create, acquire and accumulate distinct assets, intellectual properties, and exceptional technologies that provide meaningful medical solutions The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, have a substantial market opportunity.
For more information, visit: https://www.odysseyhealthinc.com
Forward-Looking Statements
This news release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including appropriate funding for the Company, economic slowdown affecting companies, our ability to successfully develop products, rapid change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions.
Media and Investors Contacts:
CG CAPITAL
Rich Cockrell
877.889.1972
investorrelations@cg.capital
FAQ
When does Odyssey Health (ODYY) plan to submit its Save A Life choking device to the FDA?
How does the ODYY Save A Life choking rescue device work?
What is the market size for Odyssey Health's choking rescue device?
What stage of development is the ODYY Save A Life device currently in?
What are the key features of Odyssey Health's Save A Life anti-choking device?
